Senhwa Biosciences Statistics

Total Valuation

TPEX:6492 has a market cap or net worth of TWD 3.60 billion. The enterprise value is 2.80 billion.

Market Cap	3.60B
Enterprise Value	2.80B

Important Dates

The last earnings date was Monday, November 10, 2025.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6492 has 89.19 million shares outstanding. The number of shares has increased by 0.20% in one year.

Current Share Class	89.19M
Shares Outstanding	89.19M
Shares Change (YoY)	+0.20%
Shares Change (QoQ)	+0.50%
Owned by Insiders (%)	2.04%
Owned by Institutions (%)	0.11%
Float	68.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3,336.20
PB Ratio	4.30
P/TBV Ratio	4.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.61
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 38.00, with a Debt / Equity ratio of 0.03.

Current Ratio	38.00
Quick Ratio	37.58
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-402.70

Financial Efficiency

Return on equity (ROE) is -27.16% and return on invested capital (ROIC) is -17.52%.

Return on Equity (ROE)	-27.16%
Return on Assets (ROA)	-17.24%
Return on Invested Capital (ROIC)	-17.52%
Return on Capital Employed (ROCE)	-32.59%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, TPEX:6492 has paid 1.28 million in taxes.

Income Tax	1.28M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.04% in the last 52 weeks. The beta is 1.08, so TPEX:6492's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	-9.04%
50-Day Moving Average	42.49
200-Day Moving Average	37.85
Relative Strength Index (RSI)	41.46
Average Volume (20 Days)	269,040

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6492 had revenue of TWD 1.08 million and -263.96 million in losses. Loss per share was -2.96.

Revenue	1.08M
Gross Profit	533,000
Operating Income	-278.27M
Pretax Income	-262.68M
Net Income	-263.96M
EBITDA	-276.07M
EBIT	-278.27M
Loss Per Share	-2.96

Full Income Statement

Balance Sheet

The company has 825.71 million in cash and 24.23 million in debt, giving a net cash position of 801.48 million or 8.99 per share.

Cash & Cash Equivalents	825.71M
Total Debt	24.23M
Net Cash	801.48M
Net Cash Per Share	8.99
Equity (Book Value)	838.82M
Book Value Per Share	9.41
Working Capital	813.18M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-258.50M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	49.35%
Operating Margin	-25,765.56%
Pretax Margin	-24,322.50%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:6492 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.20%
Shareholder Yield	-0.20%
Earnings Yield	-7.33%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6492 has an Altman Z-Score of 57.21 and a Piotroski F-Score of 2.

Altman Z-Score	57.21
Piotroski F-Score	2